Get the Stockscreener App
120.51
3.00%
-3.73
After Hours:
118.34
-2.17
-1.80%
Glaukos Corporation Stock (GKOS) Latest News
GLAUKOS Corp SEC 10-K Report - TradingView
FDA sets review date for Glaukos' keratoconus drug By Investing.com - Investing.com Australia
FDA sets review date for Glaukos’ keratoconus drug By Investing.com - Investing.com Nigeria
GKOSGlaukos Corp Latest Stock News & Market Updates - StockTitan
FDA accepts Glaukos application for Epioxa for keratoconus - MSN
Here's How Much $100 Invested In Glaukos 5 Years Ago Would Be Worth Today - Benzinga
FDA Sets Decision Date For Glaukos' Keratoconus Treatment Without The Need Of Surgery - Benzinga
Glaukos Announces FDA Acceptance of NDA Submission for Epioxa™ - BioSpace
Glaukos's Corneal Disease Drug Accepted for FDA Review -February 24, 2025 at 07:33 am EST - Marketscreener.com
FDA sets review date for Glaukos' keratoconus drug - Investing.com
Revolutionary Eye Treatment Advances: Can Glaukos Transform Keratoconus Care Without Surgery? - StockTitan
Van ECK Associates Corp Trims Position in Glaukos Co. (NYSE:GKOS) - Defense World
Glaukos (NYSE:GKOS) Price Target Raised to $160.00 - Defense World
Glaukos (GKOS) Reports Q4 Loss, Tops Revenue Estimates - MSN
Glaukos Corporation (NYSE:GKOS) Yearly Results Just Came Out: Here's What Analysts Are Forecasting For This Year - Simply Wall St
Glaukos Reports Record Sales Growth in Fourth Quarter of 2024, Announces 2025 Guidance - Vision Monday
Glaukos Q4 2024 Earnings Preview - MSN
Glaukos Corp. Reports Record Sales in Earnings Call - TipRanks
Truist maintains buy on Glaukos stock, price target steady at $185 - Investing.com Australia
Glaukos Corp earnings missed by $0.02, revenue topped estimates - Investing.com Australia
Earnings call transcript: Glaukos Corp Q4 2024 sees revenue rise but EPS miss - Investing.com Nigeria
Truist maintains buy on Glaukos stock, price target steady at $185 By Investing.com - Investing.com South Africa
GKOS Stock Falls Despite Q4 Earnings & Revenue Beat, Margins Decline - MSN
Glaukos Delivers Mixed Q4 Results, Analyst Sees Growing Investor Interest During Transition - Benzinga
BTIG cuts Glaukos stock price target to $155 from $157 By Investing.com - Investing.com Nigeria
Glaukos Corporation (NYSE:GKOS) Q4 2024 Earnings Call Transcript - Insider Monkey
Glaukos Corp Q4 2024 Earnings: Revenue Surpasses Estimates at $1 - GuruFocus.com
Glaukos price target raised to $160 from $153 at Wells Fargo - TipRanks
BTIG cuts Glaukos stock price target to $155 from $157 - Investing.com
Glaukos Corp (GKOS) Q4 2024 Earnings Call Highlights: Record Sales and Strategic Growth Amid ... - Yahoo Finance
Glaukos Announces Fourth Quarter and Full Year 2024 Financial Results - BioSpace
Glaukos: Q4 Earnings Snapshot - Danbury News Times
Glaukos Corporation Reports Strong 2024 Financial Results - TipRanks
Insider Selling: Glaukos Co. (NYSE:GKOS) Insider Sells 3,416 Shares of Stock - MarketBeat
Why Glaukos Stock is Soaring: Key Insights - TipRanks
Glaukos Corp reports results for the quarter ended December 31Earnings Summary - TradingView
Glaukos shares tumble 12% on wider-than-feared Q4 loss - Investing.com
Glaukos shares tumble 12% on wider-than-feared Q4 loss By Investing.com - Investing.com Australia
Glaukos Q4 Non-GAAP Loss Narrows, Sales Rise -February 20, 2025 at 04:37 pm EST - Marketscreener.com
Glaukos: Q4 Earnings Snapshot -February 20, 2025 at 05:52 pm EST - Marketscreener.com
Glaukos Reports Record Sales and Positive Revenue Outlook - TipRanks
Earnings Flash (GKOS) GLAUKOS CORPORATION Posts Q4 Loss $-0.40 Per Share, vs. FactSet Est of $-0.38 - Marketscreener.com
What To Expect From Glaukos Corp (GKOS) Q4 2024 Earnings - Yahoo Finance
Glaukos (NYSE:GKOS) Upgraded by Mizuho to Outperform Rating - MarketBeat
Glaukos Co. (NYSE:GKOS) Stock Holdings Trimmed by New York State Common Retirement Fund - MarketBeat
Glaukos Co. (NYSE:GKOS) Shares Sold by Peregrine Capital Management LLC - MarketBeat
Glaukos chief development officer Navratil sells $502,630 in stock - Investing.com
Glaukos chief development officer Navratil sells $502,630 in stock By Investing.com - Investing.com South Africa
Glaukos Stock Soars on Promising iDose Outlook - TipRanks
Mizuho Upgrades Glaukos (GKOS) - Nasdaq
This NetApp Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Wednesday - Benzinga
1.29%
2.68%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):